Metoject PEN is a medicine containing methotrexate used to treat conditions like rheumatoid arthritis, juvenile arthritis, psoriasis, psoriatic arthritis, and Crohn's disease by slowing down disease progression.
Your doctor will decide your specific dose. It is given as a single injection once a week.
Metoject PEN is given as an injection under the skin (subcutaneously) once a week. Your doctor or nurse will show you how to give the injection correctly. Do not attempt to self-inject unless you have been properly trained by a healthcare professional.
This medicine should only be taken once a week. Taking more than one injection per week can be dangerous and potentially fatal.
Suitable for older adults, with specific precautions. For the treatment of conditions other than cancer only once weekly. Organtoxic such as kidneys, liver and bone marrow. Reduce the dose already in mild renal impairment. Avoid use in severe renal impairment. Consider the numerous potential interactions. Remember blood tests to monitor safety. (updated 6.11.2023)